Your body already makes this hormone, but now youve got the power to boost it to help curb cravings & appetite
This echoes the findings of a 2013 review, which found neither firm evidence in favor of this hypothesis nor evidence strong enough to rule out any such increased risk. Recent research also points to a link between the GLP-1 receptor agonist semaglutide and worsening diabetic retinopathy (DR)
Additional results from the TRIUMPH program, which include a maintenance dose of 4 mg in addition to the 9 mg and 12 mg doses tested in this trial, are expected in 2026
Constipation: Can persist throughout escalation
Report persistent symptoms to your healthcare provider
Per Omzo's Terms, monthly pricing includes consultation, prescription, medication, and shipping